My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Alembic Pharma Research Report - 16th Dec 2015

Pharmaceutical | Published on Feb 11th 2011


Alembic Pharma (Alembic) reported a strong performance for 2QFY2012. The companys growth was driven by exports and the domestic formulation business (which performed better than others), as restructuring of the business segment has now started showing results. Alembic reported robust sales growth and improvement in the OPM. At the CMP, the stock is trading at attractive valuations. Hence, we maintain our Buy view on the stock.

Download Full Report


CMP 44
Target Price 77
Investment Period12 Months

Trade Securely


Portfolio Tracking & Trading Application View Demo